TRANSFORMATIVE ADVANCES IN HEALTHCARE AND ASSOCIATED ETHICAL CONSIDERATIONS

WEALTH POLICY INTERNATIONAL FOUNDATION

— 3 min read

Highly anticipated advances in healthcare, such as personalised medicine are revolutionary but such precision comes with a minefield of privacy and related concerns. Ethical and regulatory authorities will need to keep pace with such innovation to ensure privacy, avoid misuse and bias, and address concerns with public trust around AI and biotech.

Personalized and Precision Medicine

Thanks for reading! Subscribe for free to receive new posts and support my work.

Personalised medicine promises better outcomes with treatment based on an individual’s genetic, environmental, and lifestyle factors.

  • Genomic profiling will help determine the best therapies for cancer, rare diseases, and psychiatric conditions.
  • Polygenic risk scores may soon predict your risk of common diseases like diabetes or heart disease.
  • Pharmacogenomics will help avoid adverse drug reactions by matching drugs to your DNA.

AI-Powered Diagnostics and Decision Support

Artificial intelligence is becoming a core component in diagnosis and clinical workflows.

  • AI can now detect diseases like breast cancer, retinopathy, and pneumonia from imaging with superhuman accuracy.
  • Chatbots and virtual assistants will triage patients before they see a doctor.
  • AI will support doctors in real-time with clinical decision-making, reducing diagnostic errors.

Gene Editing and Therapy

CRISPR stands for Clustered Regularly Interspaced Short Palindromic Repeats. It refers to a natural defence system found in bacteria. These microbes use CRISPR to recognize and destroy viruses that have attacked them before, like a genetic memory bank. CRISPR and next-gen gene-editing tools are evolving rapidly.

  • CRISPR-based therapies for sickle cell disease, beta-thalassemia, and certain cancers are in advanced clinical trials.
  • In vivo gene editing (editing genes directly in the body) could soon become routine.
  • Gene silencing is being used to target genes involved in cholesterol, ALS, and more.

Wearables, Sensors, and Remote Monitoring

Real-time health monitoring is shifting healthcare from reactive to proactive.

  • Smartwatches can now detect atrial fibrillation, blood oxygen, and stress levels.
  • Continuous glucose monitors (CGMs) are revolutionizing diabetes care.
  • At-home diagnostics (e.g., portable ultrasound, digital stethoscopes) will grow, reducing hospital visits.

Neurotechnology and Brain Health

Better tools for understanding and treating brain disorders.

  • Brain-computer interfaces (BCIs) like those from Neuralink aim to help paralyzed patients control devices with thought.
  • Closed-loop neuromodulation could help treat epilepsy, Parkinson’s, depression, and chronic pain.
  • Advances in psychedelic-assisted therapy (e.g., psilocybin, MDMA) are showing promise for PTSD, depression, and addiction.

Regenerative Medicine and 3D Bioprinting

Repairing or replacing damaged tissues and organs.

  • 3D-printed tissues for skin, cartilage, and even mini-organs ("organoids") are entering the clinic.
  • Stem cell therapies are already approved for some blood cancers and degenerative diseases.
  • Lab-grown organs (e.g., kidney, liver) are in early stages but hold huge potential for solving transplant shortages.

Next-Gen Drugs and Delivery Systems

Smarter, more effective therapeutics are in the pipeline.

  • mRNA therapies are expanding beyond vaccines to cancer and genetic diseases.
  • Targeted protein degradation is a new class of drugs aimed at previously "undruggable" targets.
  • Nanomedicine allows precise drug delivery with fewer side effects.

Synthetic Biology and Bioengineering

Designing biological systems with engineering principles.

  • Creation of synthetic cells, engineered bacteria that detect or treat disease.
  • Potential for on-demand drug manufacturing in local clinics using bioreactors.
  • Engineering immune cells to treat cancers and autoimmune diseases.

Ethical and Legal Challenges

Existing and future apps and developments entail the collection of valuable data but carries serious risk of data misuse. Considerations include:

  • Informed consent: Patients may not fully understand how their data will be used or shared.
  • Data ownership: Who controls the data—patients, providers, or tech companies?
  • Cross-border data sharing: Global research collaborations complicate compliance with privacy laws like GDPR.
  • Genomic data: DNA sequencing reveals deeply personal information, not just about the individual but potentially about their relatives too.
  • Lifestyle tracking: Wearables and health apps collect real-time sensitive data on sleep, exercise, diet, and more.
  • Discrimination: Employers or insurers could misuse genetic data to deny coverage or employment.
  • Loss of autonomy: Algorithms might make decisions about treatment without sufficient human oversight.

To ensure regulatory oversight, laws will need to evolve to keep pace with tech-driven healthcare. Patients will expect clear communication about data use along with the strictest security protocols such as encryption, anonymisation and access controls.

Read more